CrimiC, NotoA, MadottoF, IppolitoM, NolascoS, CampisiR, et al. COVID-HIGH Investigators. High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial. Thorax, 2023; 78(4):354–361.
2.
Ospina-TasconGA, Calderon-TapiaLE, GarciaAF, ZaramaV, Gomez-AlvarezF, Alvarez-SaaT, et al. HiFLo-Covid Investigators. Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients with severe COVID-19: a randomized clinical trial. JAMA, 2021; 326(21):2161–2171.
3.
HeitmannJ, KreutzJ, AldudakS, SchiefferE, SchiefferB, SchaferA-C. A practical approach for the treatment of post-COVID symptoms. Herz, 2023; 48(3):243–246.
4.
HuangC, HuangL, WangY, LiX, RenL, GuX, et al. 6-Month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet, 2023; 401(10393):e21–e33.
5.
WongAW, ShahAS, JohnstonJC, CarlstenC, RyersonCJ. Patient-reported outcome measures after COVID-19: a prospective cohort study. Eur Respir J, 2020; 56(5):2003276.
6.
Bull-OttersonL, BacaS, SaydahS, BoehmerTK, AdjeiS, GrayS, HarrisAM. Post–COVID conditions among adult COVID-19 survivors aged 18–64 and ≥65 years—United States, Mar 2020–Nov 2021. MMWR Morb Mortal Wkly Rep, 2022; 71(21):713–717.
7.
KhorYH, DudleyKA, HermanD, JacobsSS, LedererDJ, KrishnanJA, et al. Summary for clinicians: clinical practice guideline on home oxygen therapy for adults with chronic lung disease. Ann Am Thorac Soc, 2021; 18(9):1444–1449.
8.
Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med, 1980; 93(3):391–398.
9.
Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet, 1981; 1(8222):681–686.
10.
GóreckaD, GorzelakK, SliwińskiP, TobiaszM, ZielińskiJ. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax, 1997; 52(8):674–679.
EkstromM, AhmadiZ, Bornefalk-HermanssonA, AbernethyA, CurrowD. Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy. Cochrane Database Syst Rev, 2016; 11(11):CD006429.
13.
AmeerF, CarsonKV, UsmaniZA, SmithBJ. Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at rest. Cochrane Database Syst Rev, 2014; 2014(6):CD000238.
14.
Levi-ValensiP, WeitzenblumE, PedinielliJL, RacineuxJL, DuwoosH. Three-month follow-up of arterial blood gas determinations in candidates for long-term oxygen therapy. A multicentric study. Am Rev Respir Dis, 1986; 133(4):547–551.
15.
AntonyT, AcharyaVK, RayRA, HollaR. Mental health and quality of life among patients with chronic respiratory failure on domiciliary oxygen: a prospective cohort study from a tertiary care centre in India. BMJ Open, 2023; 13(7):e067321.
16.
FreedmanMB, KimYJ, KaurR, JainBV, AdegunsoyeAO, ChungY-C, et al. Home oxygen after hospitalization for COVID-19: results from the multicenter OXFORD study. Respir Care, 2024; 69(3):281–289.
17.
NundyS, PatelKK. Hospital-at-home to support COVID-19 surge-time to bring down the walls?. JAMA Health Forum, 2020; 1(5):e200504.
18.
BoeijenJA, van de PolAC, van UumRT, SmitK, AhmadA, van RijswijkE, et al. Home-based initiatives for acute management of COVID-19 patients needing oxygen: differences across The Netherlands. BMC Health Serv Res, 2023; 23(1):1257.
19.
van GoorHMR, BretelerMJM, van LoonK, de HondTAP, ReitsmaJB, ZwartDLM, et al. Remote hospital care for recovering COVID-19 patients using telemedicine: a randomised controlled trial. J Clin Med, 2021; 10(24):5940.
20.
ZaehSE, CaseM, AuDH, DaSilvaM, DeitemeyerK, DeLisaJ, et al. Clinical practices surrounding the prescription of home oxygen in patients with COPD and desaturation. Chronic Obstr Pulm Dis, 2023; 10(4):343–354.
21.
GreenhalghT, GillP. Pressure to prescribe. BMJ, 1997; 315(7121):1482–1483.
22.
CrimiC, CortegianiA. Clinical recovery should be considered as an outcome measure in clinical trials including patients with new-onset hypoxemia. Chest, 2023; 164(5):e157–e158.
